Trexquant Investment’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
Trexquant Investment's NAGE Position: Q3 2026 in Review
Trexquant Investment sold out of Niagen Bioscience (NAGE) in Q3 2026, closing a stake of 243,186 shares — an estimated $776K sold.
Trexquant Investment first reported a position in NAGE in Q4 2017 and held it in 8 quarters. The position peaked at $4.13M in Q3 2025. 124 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.
- Trexquant Investment reported no remaining Niagen Bioscience position as of Q3 2026 after selling out during the quarter.
- Trexquant Investment sold 243,186 Niagen Bioscience shares in Q3 2026, an estimated $776K.
- Trexquant Investment first reported a position in Niagen Bioscience in Q4 2017 and held it in 8 quarters.
- Trexquant Investment's Niagen Bioscience position peaked at $4.13M in Q3 2025.
- 124 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.
Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.